Inventor · disambiguated record
Robert Kirk Delisle
Also filed as: DELISLE ROBERT K · DELISLE ROBERT KIRK
19 granted patents·5 pending applications·54 citations·filing 2003–2021
93Inventor score
Top patents by PatentIndex Score
24 records- 0189US7795282B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Sep 14, 2010·9 cites·2 claims
- 0287US9221841B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2015·Granted Dec 29, 2015·5 cites·19 claims
- 0385US8268871B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2010·Granted Sep 18, 2012·7 cites·10 claims
- 0482US8580828B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2012·Granted Nov 12, 2013·5 cites·35 claims
- 0582US8324257B2Mitotic kinesin inhibitors and methods of use thereofAHRENDT KATERI·Filed 2007·Granted Dec 4, 2012·7 cites·37 claims
- 0678US8716498B26-substituted phenoxychroman carboxylic acid derivativesARRAY BIOPHARMA INC·Filed 2013·Granted May 6, 2014·2 cites·1 claims
- 0776US9096567B26-substituted phenoxychroman carboxylic acid derivativesARRAY BIOPHARMA INC·Filed 2014·Granted Aug 4, 2015·2 cites·31 claims
- 0876US8569522B26-substituted phenoxychroman carboxylic acid derivativesBURGESS LAURENCE E·Filed 2009·Granted Oct 29, 2013·3 cites·37 claims
- 0975US9174981B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsBOYS MARK LAURENCE·Filed 2011·Granted Nov 3, 2015·3 cites·30 claims
- 1074US8785445B27-phenoxychroman carboxylic acid derivativesCOOK ADAM·Filed 2009·Granted Jul 22, 2014·4 cites·14 claims
- 1174US8557809B2Triazolopyridine compounds as PIM kinase inhibitorsALLEN SHELLEY·Filed 2009·Granted Oct 15, 2013·2 cites·17 claims
- 1272US9809590B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Nov 7, 2017·1 cites·29 claims
- 1372US9556139B26-substituted phenoxychroman carboxylic acid derivativesARRAY BIOPHARMA INC·Filed 2015·Granted Jan 31, 2017·1 cites·14 claims
- 1471US8575145B2Triazolopyridine compounds as PIM kinase inhibitorsALLEN SHELLEY·Filed 2009·Granted Nov 5, 2013·2 cites·29 claims
- 1567US10669269B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
- 1663US2023024434A1Methods for Developing Personalized Drug Treatment Plans and Targeted Drug Development Based on Proteomic ProfilesSOMALOGIC INC·Filed 2021·Application pending·0 cites
- 1762US8841455B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitorsBOYS MARK LAURENCE·Filed 2010·Granted Sep 23, 2014·1 cites·41 claims
- 1861US2014018399A1Mitotic kinesin inhibtors and methods of use thereofARRAY BIOPHARMA INC·Filed 2013·Application pending·0 cites
- 1955US2006128699A1Novel pharmacophore for the discovery and testing of na,k-atpase inhibitor compositions and methods for their use in treating cardiovascular diseases and conditionsWELSH WILLIAM J·Filed 2003·Application pending·0 cites
- 2054US2018284136A1Compositions and methods for identifying, modulating and monitoring drug targets in muscular diseaseSOMALOGIC INC·Filed 2018·Application pending·0 cites
- 2150US8895550B2Triazolopyridine compounds as PIM kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Nov 25, 2014·0 cites·22 claims
- 2244US8987251B2Triazolopyridine compounds as PIM kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Mar 24, 2015·0 cites·33 claims
- 2344US2018259533A1Methods for developing personalized drug treatment plans and targeted drug development based on proteomic profilesSOMALOGIC INC·Filed 2016·Application pending·0 cites
- 2438US8889704B2Triazolopyridine compounds as PIM kinase inhibitorsBLAKE JAMES F·Filed 2012·Granted Nov 18, 2014·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Robert Kirk Delisle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →